In vitro platforms for evaluating liver toxicity

…, A Bakan, A Bhushan, TY Shun… - Experimental …, 2014 - journals.sagepub.com
The liver is a heterogeneous organ with many vital functions, including metabolism of
pharmaceutical drugs and is highly susceptible to injury from these substances. The etiology of …

Development of a 384-well colorimetric assay to quantify hydrogen peroxide generated by the redox cycling of compounds in the presence of reducing agents

…, SN Shinde, CA Foster, TY Shun… - Assay and drug …, 2008 - liebertpub.com
We report here the development and optimization of a simple 384-well colorimetric assay to
measure H 2 O 2 generated by the redox cycling of compounds incubated with reducing …

Profiling the NIH Small Molecule Repository for Compounds That Generate H2O2 by Redox Cycling in Reducing Environments

KM Soares, N Blackmon, TY Shun… - Assay and drug …, 2010 - liebertpub.com
We have screened the Library of Pharmacologically Active Compounds (LOPAC) and the
National Institutes of Health (NIH) Small Molecule Repository (SMR) libraries in a horseradish …

[HTML][HTML] Automated High-Content Live Animal Drug Screening Using C. elegans Expressing the Aggregation Prone Serpin α1-antitrypsin Z

…, DE King, KJ Kovatch, PA Johnston, TY Shun… - PloS one, 2010 - journals.plos.org
The development of preclinical models amenable to live animal bioactive compound screening
is an attractive approach to discovering effective pharmacological therapies for disorders …

HTS identifies novel and specific uncompetitive inhibitors of the two-component NS2B-NS3 proteinase of West Nile virus

PA Johnston, J Phillips, TY Shun, S Shinde… - Assay and drug …, 2007 - liebertpub.com
West Nile virus (WNV), a member of the Flavividae family, is a mosquito-borne, emerging
pathogen. In addition to WNV, the family includes dengue, yellow fever, and Japanese …

Biologically relevant heterogeneity: metrics and practical insights

…, AM Stern, J Maier, T Lezon, TY Shun… - … Life Sciences R&D, 2017 - journals.sagepub.com
Heterogeneity is a fundamental property of biological systems at all scales that must be
addressed in a wide range of biomedical applications, including basic biomedical research, drug …

[HTML][HTML] Towards a three-dimensional microfluidic liver platform for predicting drug efficacy and toxicity in humans

…, L Vernetti, A Gough, A Bakan, TY Shun… - Stem cell research & …, 2013 - Springer
Although the process of drug development requires efficacy and toxicity testing in animals
prior to human testing, animal models have limited ability to accurately predict human …

Identifying actives from HTS data sets: practical approaches for the selection of an appropriate HTS data-processing method and quality control review

TY Shun, JS Lazo, ER Sharlow… - Journal of …, 2011 - journals.sagepub.com
High-throughput screening (HTS) has achieved a dominant role in drug discovery over the
past 2 decades. The goal of HTS is to identify active compounds (hits) by screening large …

[HTML][HTML] Identifying and quantifying heterogeneity in high content analysis: application of heterogeneity indices to drug discovery

AH Gough, N Chen, TY Shun, TR Lezon, RC Boltz… - PloS one, 2014 - journals.plos.org
One of the greatest challenges in biomedical research, drug discovery and diagnostics is
understanding how seemingly identical cells can respond differently to perturbagens including …

Identification of survival genes in human glioblastoma cells by small interfering RNA screening

NG Thaker, F Zhang, PR McDonald, TY Shun… - Molecular …, 2009 - ASPET
Target identification and validation remain difficult steps in the drug discovery process, and
uncovering the core genes and pathways that are fundamental for cancer cell survival may …